Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment-Reference-Cited by-同舟云学术

Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment

Published:2017-10-16 Issue:1 Volume:47 Page:104-113
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Ogawa E.¹^ORCID,Furusyo N.¹,Nomura H.²,Dohmen K.¹,Higashi N.²,Takahashi K.¹,Kawano A.²,Azuma K.¹,Satoh T.²,Nakamuta M.¹,Koyanagi T.¹,Kato M.¹,Shimoda S.¹,Kajiwara E.²,Hayashi J.¹,

Affiliation:

1. Fukuoka Japan

2. Kitakyushu Japan

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14380/fullpdf

Reference32 articles.

1. Natural history of chronic hepatitis C;Seeff;Hepatology,2002

2. Natural history of hepatitis C;Westbrook;J Hepatol,2014

3. Effectiveness of sofosbuvir, ledipasvir/sofosbuvir, or paritaprevir/ritonavir/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the Veterans Affairs national health care system;Ioannou;Gastroenterology,2016

4. Real-world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment-naive, genotype 1 hepatitis C-infected patients;Backus;Hepatology,2016

5. NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b;Ogawa;J Gastroenterol,2017

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong;BMC Gastroenterology;2024-01-25

2. Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients;Journal of the Chinese Medical Association;2024-01-05

3. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01

4. Characterization of circulating miRNAs in the treatment of primary liver tumors;Cancer Reports;2023-12-25

5. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?;Viruses;2023-12-17